<DOC>
	<DOCNO>NCT00928408</DOCNO>
	<brief_summary>This multicentre , descriptive observational study adult patient primary HPT receive cinacalcet clinical practice number country Europe . Patients enrol within 1 month initiate cinacalcet treatment , data collect prospectively 1 year initiation . Data continue collect patient discontinue cinacalcet end period .</brief_summary>
	<brief_title>PRIMARA : A Prospective Descriptive Observational Study Review Mimpara ( Cinacalcet ) Use Patients With Primary Hyperparathyroidism Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Primary</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>least 18 year age time first administration cinacalcet patient primary HPT initiate cinacalcet within 1 month enrolment study provision inform consent ( require ) previous use cinacalcet ( within 1 month enrolment ) diagnose secondary HPT known aetiology hypercalcaemia ( eg , sarcoidosis , tuberculosis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>